215 related articles for article (PubMed ID: 26320178)
1. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.
Qin CJ; Song XM; Chen ZH; Ren XQ; Xu KW; Jing H; He YL
Oncotarget; 2015 Oct; 6(31):32193-204. PubMed ID: 26320178
[TBL] [Abstract][Full Text] [Related]
2. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer.
Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ
Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
[TBL] [Abstract][Full Text] [Related]
4. PSMB8 as a Candidate Marker of Responsiveness to Preoperative Radiation Therapy in Rectal Cancer Patients.
Ha YJ; Tak KH; Kim CW; Roh SA; Choi EK; Cho DH; Kim JH; Kim SK; Kim SY; Kim YS; Kim JC
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1164-1173. PubMed ID: 28721901
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.
Wang L; Zhang XM; Li Z; Liu XJ; Chai J; Zhang GY; Cheng YF
World J Gastroenterol; 2013 Oct; 19(40):6876-82. PubMed ID: 24187464
[TBL] [Abstract][Full Text] [Related]
8. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma.
Yu ZQ; Zhang C; Wang H; Lao XY; Chai R; Gao XH; Cao GW; Fu CG
Dis Colon Rectum; 2013 May; 56(5):600-8. PubMed ID: 23575399
[TBL] [Abstract][Full Text] [Related]
10. Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death.
Shang ZF; Wei Q; Yu L; Huang F; Xiao BB; Wang H; Song M; Wang L; Zhou J; Wang J; Li S
Oncotarget; 2016 Sep; 7(38):62340-62351. PubMed ID: 27694690
[TBL] [Abstract][Full Text] [Related]
11. RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase-9-caspase-3-dependent apoptotic pathway.
Yan X; Chen J; Meng Y; He C; Zou S; Li P; Chen M; Wu J; Ding WQ; Zhou J
Cancer Med; 2019 Jun; 8(6):3094-3104. PubMed ID: 31033216
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1.
Kim SC; Shin YK; Kim YA; Jang SG; Ku JL
BMC Cancer; 2018 May; 18(1):594. PubMed ID: 29801473
[TBL] [Abstract][Full Text] [Related]
13. Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients.
Napolitano M; D'Alterio C; Cardone E; Trotta AM; Pecori B; Rega D; Pace U; Scala D; Scognamiglio G; Tatangelo F; Cacciapuoti C; Pacelli R; Delrio P; Scala S
Oncotarget; 2015 Apr; 6(10):8261-70. PubMed ID: 25823653
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer.
Seo I; Lee HW; Byun SJ; Park JY; Min H; Lee SH; Lee JS; Kim S; Bae SU
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692216
[TBL] [Abstract][Full Text] [Related]
15. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
16. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway.
Yu Z; Zhang C; Wang H; Xing J; Gong H; Yu E; Zhang W; Zhang X; Cao G; Fu C
Cancer Lett; 2014 Oct; 353(2):182-93. PubMed ID: 25088576
[TBL] [Abstract][Full Text] [Related]
18. Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer: a feasibility study.
Supiot S; Gouraud W; Campion L; Jezéquel P; Buecher B; Charrier J; Heymann MF; Mahé MA; Rio E; Chérel M
World J Gastroenterol; 2013 Jun; 19(21):3249-54. PubMed ID: 23745026
[TBL] [Abstract][Full Text] [Related]
19. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
